valrubicinpembrolizumabnadofaragene firadenovecDurvalumaberdafitinib
…ducted, no agents have received approval, with the exception of valrubicin, largely attributed to factors such as the varied prior BCG exp…
3articles mentioning drugs
6drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: disitamab vedotin ×
disitamab vedotin
This drug is selected. Its supporting articles are shown below.
Articles mentioning disitamab vedotin
3 articles · page 1 of 1disitamab vedotintrastuzumab deruxtecanT-DXdgastric canceranti-HER2 therapy
…ody-drug conjugates, such as trastuzumab deruxtecan (T-DXd) and disitamab vedotin (RC48), has been pivotal in rendering ‘HER-2-low’ gastric cance…
lenvatinibRC48Disitamab vedotinHuazhong University of Science and TechnologyTongji Medical CollegeChemotherapyadvanced biliary tract cancer (BTC)human epidermal growth factor receptor 2 (HER2)-positive BTCUnion Hospital
…e enrolled in this study to receive the combination of RC48 and lenvatinib. The primary study endpoint is objective response rate, and the…